India's cancer care infrastructure is growing at 15%+ annually. Entering this market requires deep hospital relationships, AERB regulatory expertise and proven local logistics. Saxsons Group brings all three — built since 1986.
The India Opportunity
Nuclear medicine and radiotherapy consumables require AERB licensing for import. Without a licensed Indian partner, market entry is not feasible — Saxsons is that partner.
Why Saxsons
We don't just distribute — we build markets. Our partners grow their India revenue year on year because Saxsons functions as their India team, not just their courier.
Direct access to nuclear medicine departments, radiotherapy centres, oncosurgery OTs and cyclotron facilities across India — relationships built over 40+ years that no new entrant can replicate quickly.
Import licences, AERB regulatory submissions, customs clearance, documentation and end-of-life radioactive source return — all managed in-house. Entering India's nuclear medicine market without an AERB partner is not feasible.
Proven cold-chain logistics covering metro cities and Tier-2 centres. Right. On Time. — our core promise is your product's reputation in the field. We handle the last-mile complexity so you never need to.
In-house technical team for product training, installation commissioning and ongoing after-sales support across India. Your warranty and service commitments are honoured without you needing a local presence.
Deep insight into tendering patterns, key opinion leaders, procurement cycles and formulary pathways. Our partners consistently report year-on-year India market share growth backed by CMEs, demos and clinical education programmes.
We don't transact — we build markets. Our existing principals have been with us for 5–20+ years. We invest deeply in understanding and growing your product's India story, treating it as our own.
The Process
A straightforward, transparent process — typically 3–6 months from first call to first hospital placement.
Tell us about your company, products and the category you're in. Our partnerships team reviews every enquiry personally.
We schedule a discovery call to understand your product portfolio, clinical claims, regulatory status and market ambitions for India.
We share a distribution proposal covering territory, targets, regulatory pathway and commercial terms. Once agreed, we sign a distribution agreement.
Saxsons handles AERB/import approvals, clinical training and market introduction. Your product is in front of 1,000+ hospitals within months.
Open for Partnerships
If your product fits any of these clinical categories, we want to hear from you.
Our Track Record
These manufacturers trusted Saxsons with their India market — and have seen consistent year-on-year market share growth.
Get Started
Tell us about your company and products. Our partnerships team responds within 2 business days.
Enquiry submitted!
Our partnerships team will respond within 2 business days.
Submission failed — please try again or email us directly at saxsons@saxsons.com.